Is Ocular Therapeutix, Inc. (OCUL) a Buy, Sell, or Hold?
NASDAQ : OCUL
Ocular Therapeutix, Inc.
$9.96 USD
$0.26 (2.68%)
- Volume
- 1.3M
- Average Volume
- 2.88M
- Market Capitalization
- $2.18B
- P/E Ratio
- -6.82
- Dividend Yield
- 0.00%
- Price Target
- $30.00
- Year High
- $16.44
- Year Low
- $6.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.81
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
42
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
34
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$1.3M
OCUL Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
OCUL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Dugel Pravin | director, officer: See Remarks | 2026-06-16 | G-Gift | 0 | 2026-06-18 |
| Dugel Pravin | director, officer: See Remarks | 2026-06-16 | G-Gift | 0 | 2026-06-18 |
| Warden Charles M | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Warden Charles M | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| Graves Adrienne L | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Graves Adrienne L | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| Robins Jason Shand | officer: Chief Financial Officer | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Robins Jason Shand | officer: Chief Financial Officer | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| Hong Seung Suh | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Hong Seung Suh | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| LINDSTROM RICHARD L MD | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| LINDSTROM RICHARD L MD | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| RAINES MERILEE | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| RAINES MERILEE | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| Williams Leslie J. | director | 2026-06-10 | A-Award | 0 | 2026-06-12 |
| Williams Leslie J. | director | 2026-06-10 | A-Award | 8.74 | 2026-06-12 |
| Waheed Nadia | officer: Chief Medical Officer | 2026-06-03 | S-Sale | 8.27 | 2026-06-05 |
| Dugel Pravin | director, officer: See Remarks | 2026-05-26 | S-Sale | 8.2 | 2026-05-28 |
| Dugel Pravin | director, officer: See Remarks | 2026-05-28 | G-Gift | 0 | 2026-05-28 |
| Dugel Pravin | director, officer: See Remarks | 2026-05-28 | G-Gift | 0 | 2026-05-28 |
| Kaiser Peter | officer: Chief Development Officer | 2026-05-26 | S-Sale | 8.2 | 2026-05-28 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2026-05-26 | S-Sale | 8.2 | 2026-05-28 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2026-05-26 | S-Sale | 8.2 | 2026-05-28 |
| Dugel Pravin | director, officer: See Remarks | 2026-04-09 | G-Gift | 0 | 2026-04-13 |
| Dugel Pravin | director, officer: See Remarks | 2026-04-09 | G-Gift | 0 | 2026-04-13 |
| Dugel Pravin | director, officer: See Remarks | 2026-02-23 | S-Sale | 8.28 | 2026-02-25 |
| Kaiser Peter | officer: Chief Development Officer | 2026-02-23 | S-Sale | 8.28 | 2026-02-25 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2026-02-23 | S-Sale | 8.28 | 2026-02-25 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2026-02-23 | S-Sale | 8.28 | 2026-02-25 |
| Waheed Nadia | officer: Chief Medical Officer | 2026-02-20 | S-Sale | 7.74 | 2026-02-24 |
| LINDSTROM RICHARD L MD | director | 2026-02-20 | P-Purchase | 7.66 | 2026-02-24 |
| Notman Donald | officer: Chief Operating Officer | 2026-02-12 | S-Sale | 9.04 | 2026-02-17 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2026-02-12 | S-Sale | 9.04 | 2026-02-17 |
| Dugel Pravin | director, officer: See Remarks | 2026-02-12 | S-Sale | 9.04 | 2026-02-17 |
| Waheed Nadia | officer: Chief Medical Officer | 2026-02-12 | S-Sale | 9.04 | 2026-02-17 |
| Notman Donald | officer: Chief Operating Officer | 2026-02-02 | S-Sale | 9.14 | 2026-02-04 |
| Notman Donald | officer: Chief Operating Officer | 2026-02-04 | S-Sale | 8.54 | 2026-02-04 |
| Robinson David Wayne | officer: Global CCO | 2026-01-21 | A-Award | 11.42 | 2026-01-26 |
| Robinson David Wayne | officer: Global CCO | 2026-01-21 | A-Award | 0 | 2026-01-26 |
| Robinson David Wayne | officer | 2026-01-21 | 0 | 2026-01-26 | |
| Robins Jason Shand | officer: Interim CFO | 2026-01-20 | A-Award | 11.45 | 2026-01-22 |
| Robins Jason Shand | officer: Interim CFO | 2026-01-20 | 0 | 2026-01-22 | |
| Robins Jason Shand | officer: Interim CFO | 2026-01-20 | 8.12 | 2026-01-22 | |
| Robins Jason Shand | officer: Interim CFO | 2026-01-20 | 11.82 | 2026-01-22 | |
| Anderman Todd | officer: Chief Legal Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Anderman Todd | officer: Chief Legal Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Kaiser Peter | officer: Chief Development Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Kaiser Peter | officer: Chief Development Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Saroj Namrata | officer: Chief Business Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Saroj Namrata | officer: Chief Business Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Waheed Nadia | officer: Chief Medical Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Waheed Nadia | officer: Chief Medical Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Notman Donald | officer: See Remarks | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Notman Donald | officer: See Remarks | 2026-01-02 | A-Award | 11.82 | 2026-01-06 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2025-11-24 | S-Sale | 12.04 | 2025-11-26 |
| Dugel Pravin | director, officer: See Remarks | 2025-11-24 | S-Sale | 12.04 | 2025-11-26 |
| Dugel Pravin | director, officer: See Remarks | 2025-11-26 | G-Gift | 0 | 2025-11-26 |
| Dugel Pravin | director, officer: See Remarks | 2025-11-26 | G-Gift | 0 | 2025-11-26 |
| Kaiser Peter | officer: Chief Development Officer | 2025-11-24 | S-Sale | 12.02 | 2025-11-26 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2025-11-24 | S-Sale | 12.04 | 2025-11-26 |
| Saroj Namrata | officer: Chief Business Officer | 2025-11-05 | S-Sale | 10.74 | 2025-11-07 |
| Anderman Todd | officer: Chief Legal Officer | 2025-10-08 | S-Sale | 12.34 | 2025-10-10 |
| Kaiser Peter | officer: Chief Development Officer | 2025-10-02 | S-Sale | 11.03 | 2025-10-06 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2025-10-02 | S-Sale | 11.04 | 2025-10-06 |
| Dugel Pravin | director, officer: See Remarks | 2025-09-09 | G-Gift | 0 | 2025-09-11 |
| Dugel Pravin | director, officer: See Remarks | 2025-09-09 | G-Gift | 0 | 2025-09-11 |
| Notman Donald | officer: See Remarks | 2025-09-02 | S-Sale | 12.43 | 2025-09-04 |
| Kaiser Peter | officer: Chief Development Officer | 2025-08-25 | S-Sale | 12.04 | 2025-08-27 |
| Nayak Sanjay | officer: Chief Strategy Officer | 2025-08-25 | S-Sale | 12.04 | 2025-08-27 |
| Heier Jeffrey S. | officer: Chief Scientific Officer | 2025-08-25 | S-Sale | 12.04 | 2025-08-27 |
| Dugel Pravin | director, officer: See Remarks | 2025-08-25 | S-Sale | 12.04 | 2025-08-27 |
| Waheed Nadia | officer: Chief Medical Officer | 2025-08-12 | A-Award | 0 | 2025-08-14 |
| Waheed Nadia | officer: Chief Medical Officer | 2025-08-12 | A-Award | 12.48 | 2025-08-14 |
| Dugel Pravin | director, officer: See Remarks | 2025-04-28 | G-Gift | 0 | 2025-08-13 |
| Dugel Pravin | director, officer: See Remarks | 2025-06-12 | G-Gift | 0 | 2025-08-13 |
| Dugel Pravin | director, officer: See Remarks | 2025-08-11 | G-Gift | 0 | 2025-08-13 |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2025-06-11 | 0 | 2025-06-23 | |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2025-06-11 | 5.18 | 2025-06-23 | |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2025-06-11 | 5.22 | 2025-06-23 | |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2025-06-11 | 3.88 | 2025-06-23 | |
| Meyers Steve Lawrence | officer: Chief Commercial Officer | 2025-06-11 | 7.44 | 2025-06-23 | |
| Saroj Namrata | officer: Chief Business Officer | 2025-06-11 | 0 | 2025-06-23 | |
| Saroj Namrata | officer: Chief Business Officer | 2025-06-11 | 10.27 | 2025-06-23 | |
| Saroj Namrata | officer: Chief Business Officer | 2025-06-11 | 9.95 | 2025-06-23 | |
| Dugel Pravin | director, officer: See Remarks | 2025-06-11 | A-Award | 7.44 | 2025-06-13 |
| Hong Seung Suh | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Hong Seung Suh | director | 2025-06-11 | A-Award | 8.82 | 2025-06-13 |
| RAINES MERILEE | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| RAINES MERILEE | director | 2025-06-11 | A-Award | 8.82 | 2025-06-13 |
| LINDSTROM RICHARD L MD | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| LINDSTROM RICHARD L MD | director | 2025-06-11 | A-Award | 8.82 | 2025-06-13 |
| Williams Leslie J. | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |
| Williams Leslie J. | director | 2025-06-11 | A-Award | 8.82 | 2025-06-13 |
| Warden Charles M | director | 2025-06-11 | A-Award | 0 | 2025-06-13 |